Dr. Morishima is an Associate Professor of Laboratory Medicine at the University of Washington (UW). She completed medical school and pediatric residency training at Washington University in St. Louis, and her fellowship training in pediatric rheumatology at Seattle Children's Hospital. Dr. Morishima did her post-doctoral research training in the UW Department of Immunology studying central tolerance induction by viral superantigens, and subsequently developed a translational research program focused on the human immune response during chronic hepatitis C virus infection. Dr. Morishima is currently director of the Immunologic Monitoring Laboratory within the Tumor Vaccine Group and for the NCI-sponsored Cancer Immunotherapy Trials Network.
Associate Professor, Laboratory Medicine at the UW